Characteristics
|
Placebo/Routine Care
|
Levamisole/ Routine Care
|
---|
Sex, No. (%)
|
Male
|
13 (52.0)
|
17 (68.0%)
|
Female
|
12 (48.0)
|
8 (32.0%)
|
Age, median (IQR), y
|
|
32.0 (15)
|
30.0 (14)
|
Weight, median (IQR), kg
|
|
70.0 (18)
|
74.0 (18)
|
Marital status, No. (%)
|
Single
|
6 (24.0)
|
6 (24.0)
|
Married
|
19 (76.0)
|
19 (76.0)
|
Smoking, No. (%)
|
Yes
|
2 (8.0)
|
4 (16.0)
|
No
|
23 (92.0)
|
21 (84.0)
|
Mean of room-air O2 Sats, %
|
|
96.50
|
96.33
|
Lung CT-Scan involvement, No. (%)
|
Positive
|
22 (88.0)
|
22 (88.0)
|
Negative
|
0 (0.0)
|
2 (8.0)
|
None
|
3 (12.0)
|
1 (4.0)
|
Lung CT-Scan involvement Score, %
|
|
2.50
|
2.75
|
PCR, No. (%)
|
Positive
|
24 (96.0)
|
22 (88.0)
|
Negative
|
1 (4.0)
|
3 (12.0)
|
Coexisting conditions, No. (%)
|
Cardiovascular disease
|
1 (4.0)
|
0 (0.0)
|
Hypertension
|
2 (8.0)
|
1 (4.0)
|
Diabetes
|
3 (12.0)
|
1 (4.0)
|
Asthma
|
0 (0.0)
|
2 (8.0)
|
Hypothyroidism
|
1 (4.0)
|
0 (0.0)
|
- No Number, y year, kg kilogram, O2 Sats oxygen saturation, CT-Scan Computed Tomography Scan, CT involvement Score Scoring the severity by the percentages of each of the five lobes that is involved: 1 for < 5%, 2 for 5–25%, 3 for 26–49%, 4 for 50–75%, and > 75% involvement. The total score is the sum of the individual lobar scores [19], PCR polymerase chain reaction